Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1729–1752 of 18,249 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Evidence-Based Practice, Nurse's Role
Interventions: CTEP EBP Immersion; Behavioral
Lead sponsor: David Grant U.S. Air Force Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Fairfield, California

Conditions: Shoulder Pain
Interventions: Exercises; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cerebral Palsy
Interventions: Let's Move Motor Intervention; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 8 Months
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Opioid-Induced Constipation
Interventions: Methylnaltrexone, Placebo; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 237 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 29
States / cities: Mobile, Alabama • Laguna Hills, California • Lancaster, California + 23 more

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Indacaterol 150 μg, Tiotropium 18 μg, Placebo to indacaterol; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 40 Years and older
Enrollment: 1,142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 116
States / cities: Anniston, Alabama • Birmingham, Alabama • Jasper, Alabama + 102 more

Conditions: Irritable Bowel Syndrome With Diarrhea
Interventions: BEKINDA, Placebo; Drug
Lead sponsor: RedHill Biopharma Limited; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 16
States / cities: Huntsville, Alabama • Little Rock, Arkansas • North Little Rock, Arkansas + 12 more

Conditions: Congenital Diaphragmatic Hernia
Interventions: Fetal Treatment arm (FETO Group); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Health Insurance
Interventions: Kentucky HEALTH; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 64 Years
Enrollment: 378,828 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Frankfort, Kentucky • Bethesda, Maryland

Conditions: Postoperative Pain, Nausea and Vomiting, Postoperative, Dizziness, Constipation, Duration of Response, Narcotics Consumption, Pain After Surgery
Interventions: Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks, Ropivacaine with low, non weight based Dexamethasone additive; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Burns
Interventions: Fish skin, Cadaver skin; Device
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetic Gastroparesis
Interventions: 10 mg TZP-102, Placebo; Drug
Lead sponsor: Tranzyme, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 23
States / cities: Huntsville, Alabama • Tucson, Arizona • North Little Rock, Arkansas + 19 more

Conditions: Herpes Zoster, Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 35 Years to 49 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Distracted Driving, Impaired Driving, Driving Behaviors
Interventions: Persuasive education, WOOP (aka, mental contrasting with implementation intentions., Wish, Outcome, Obstacle, Plan), Customized Habit Tips, Raffle Financial Incentive, Shared Pot Financial Incentive, Weekly SMS Support text, Weekly SMS Encouragement; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 1,139 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Back Pain, Opioid Use
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Pain, Headache
Interventions: pain self management app on smartphone; Behavioral
Lead sponsor: Stephen F Butler, PhD; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Newton, Massachusetts

Conditions: Autism Spectrum Disorder (ASD)
Interventions: BUMETANIDE (S95008) for week 0 - 26, PLACEBO for week 0 - 26, Open-Label BUMETANIDE (S95008) for weeks 26 - 52; Drug
Lead sponsor: Institut de Recherches Internationales Servier; Other
Eligibility: 2 Years to 6 Years
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Staten Island, New York

Conditions: Visual Acuity
Interventions: senofilcon A, Control; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Postoperative Nausea and Vomiting
Interventions: Intravenous fluid, D5LR or lactated ringers; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Moderate Non-proliferative Diabetic Retinopathy
Interventions: Alpha Lipoic Acid; Dietary Supplement
Lead sponsor: Ferris State University; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Big Rapids, Michigan • Grand Rapids, Michigan

Conditions: Gingivitis
Interventions: Oscillating rotating power toothbrush; Device
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Chronic Disease
Interventions: Educational print materials and coaching call; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Postoperative Pain, Narcotic Use, Cryotherapy Effect
Interventions: Opioid-sparing multimodal pain management, Usual care; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Musculoskeletal Pain
Interventions: Live Preferential Music; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 304 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Music, Autonomic State
Interventions: Augmented Theme, Mahler Theme; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Search by objective public record fields.

Feasibility and Effectiveness of the Advancing Research and Clinical Practice Through Close Collaboration (ARCC)

Physical Therapy Program for Prevention of Shoulder Pain After Device Implant

Motor Training for Infants With Cerebral Palsy

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

Evaluation of the Health and Economic Consequences of Kentucky's Section 1115 Demonstration Waiver

Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns

Diabetic Gastroparesis Efficacy/Safety Study of TZP-102

Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

Increasing Seat Belt Wearing and Decreasing Handheld Phone Use While Driving

Adaptations of the Brain in Chronic Pain With Opioid Exposure I

An Intervention to Improve Adolescent Headache Self-management

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers

A Closer Look at the Effect of Dextrose on Postoperative Nausea and Vomiting

The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

Powertoothbrushing for Treating Gingivitis

Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial

Novel Multimodal Pain Control Protocol for Minimally Invasive Gynecologic Surgery

Music in Urgent and Emergent Settings

Listening to Calming Music